The Impact of Colorectal Cancer Screening on Surgical Outcomes

Launched by FUDAN UNIVERSITY · May 15, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how colorectal cancer (CRC) screening affects the outcomes of surgery for patients with stage III cancer. The researchers want to understand the characteristics of tumors and how well patients do after surgery when their cancer is detected through screening. They will collect information about patients' ages, gender, tumor locations, types of surgery, and other important factors to see how screening influences recovery and survival.

To be eligible for this study, participants need to be between the ages of 65 and 74, have been diagnosed with stage III CRC, and have had surgery to remove the cancer. They should not have had any other types of cancer before this diagnosis. While the trial is not yet recruiting participants, those who join can expect to provide detailed information about their cancer journey, helping researchers learn more about the benefits of screening in improving surgical outcomes for colorectal cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients who underwent radical surgery for CRC, had confirmed stage III CRC through postoperative pathology, had no prior history of cancer before surgery, and had clear cancer detection information.